UK TimesUK Times
  • Home
  • News
  • TV & Showbiz
  • Money
  • Health
  • Science
  • Sports
  • Travel
  • More
    • Web Stories
    • Trending
    • Press Release
What's Hot

A45 westbound access at a minor junction between B573 near Earls Barton and A5076 near Northampton (east) | Westbound | Road Works

22 July 2025

63 homes in Ashton Vale evacuated in major incident | UK News

22 July 2025

Lauren James suffers injury blow as Lionesses fight for place in Euro 2025 final – UK Times

22 July 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
UK TimesUK Times
Subscribe
  • Home
  • News
  • TV & Showbiz
  • Money
  • Health
  • Science
  • Sports
  • Travel
  • More
    • Web Stories
    • Trending
    • Press Release
UK TimesUK Times
Home » People on weight loss drugs drugs like Ozempic and Wegovy may start to regain weight within weeks of discontinuing them – UK Times
News

People on weight loss drugs drugs like Ozempic and Wegovy may start to regain weight within weeks of discontinuing them – UK Times

By uk-times.com22 July 2025No Comments3 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest Email

Sign up for our free Health Check email to receive exclusive analysis on the week in health

Get our free Health Check email

Get our free Health Check email

Health Check

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a new study finds.

The research review, published on Tuesday in the journal BMC Medicine, assessed data from 11 previous clinical trials, involving nearly 2,500 people, and found a broad trend of patients regaining lost weight after their medication courses concluded.

At least six drugs have so far been approved for treating obesity in adults – orlistat, naltrexone-bupropion, semaglutide, liraglutide, tirzepatide, and phentermine-topiramate.

Six of the 11 clinical trials covered in the review focused on semaglutide, the active ingredient of Ozempic and Wegovy.

While a growing body of research shows that prolonged use of these anti-obesity drugs can lead to significant weight loss in adults, preliminary studies indicate weight regain after their discontinuation.

“The long-term change of weight after discontinuation of AOMs is still lacking systematic evaluation,” the new review notes, referring to anti-obesity medications.

Initially given to patients with obesity and type 2 diabetes, semaglutide is now sold off-label as a quick fix for weight loss.

Researchers, including from the Peking University People’s Hospital in China, have now found that while semaglutide and similar medications could lead to significant weight loss in use, a weight rebound could start barely eight weeks after their discontinuation.

Representational. A pharmacy owner speaks with a customer at a pharmacy in Pristina
Representational. A pharmacy owner speaks with a customer at a pharmacy in Pristina (AFP via Getty)

In the review, researchers analysed data from 1,574 participants in treatment groups and 893 in control groups across 11 clinical trials, which measured weight change by tracking body weight and BMI after stopping medication.

Researchers controlled for contributing factors, including medication type, presence of diabetes, and presence or absence of lifestyle changes like diet or exercise. The analysis found that the weight rebound continued for an average of 20 weeks after discontinuation before plateauing.

“Significant weight regain occurred eight weeks after discontinuation of AOMs and was sustained through 20 weeks,” they write in the review.

Participants experienced significant periods of weight regain at eight, 12, and 20 weeks after stopping the drugs, the study found.

The weight rebound seemed to depend on factors like the type of medication taken and the consistency of lifestyle change.

For instance, patients who completed a 36-week treatment of weight-loss drug tirzepatide regained almost half the weight previously lost after switching to a placebo.

The review calls for more studies with longer follow-up periods to further assess potential factors linked to weight change after halting treatment with such drugs.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related News

A45 westbound access at a minor junction between B573 near Earls Barton and A5076 near Northampton (east) | Westbound | Road Works

22 July 2025

63 homes in Ashton Vale evacuated in major incident | UK News

22 July 2025

Lauren James suffers injury blow as Lionesses fight for place in Euro 2025 final – UK Times

22 July 2025

M4 J17 eastbound access | Eastbound | Road Works

22 July 2025

New York City has become so unaffordable residents are giving up their pets – and shelters are packed to the gills – UK Times

22 July 2025

A1(M) J60 northbound access | Northbound | Road Works

22 July 2025
Top News

A45 westbound access at a minor junction between B573 near Earls Barton and A5076 near Northampton (east) | Westbound | Road Works

22 July 2025

63 homes in Ashton Vale evacuated in major incident | UK News

22 July 2025

Lauren James suffers injury blow as Lionesses fight for place in Euro 2025 final – UK Times

22 July 2025

Subscribe to Updates

Get the latest UK news and updates directly to your inbox.

© 2025 UK Times. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact Us

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version